Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Medicare | 51 | 2024 | 6770 | 4.520 |
Why?
|
Cardiovascular Diseases | 34 | 2024 | 15498 | 3.050 |
Why?
|
Myocardial Infarction | 30 | 2024 | 11458 | 2.940 |
Why?
|
Economics, Hospital | 6 | 2024 | 210 | 2.920 |
Why?
|
Patient Readmission | 23 | 2024 | 3269 | 2.900 |
Why?
|
Medicaid | 17 | 2024 | 2818 | 2.790 |
Why?
|
Cardiovascular System | 5 | 2024 | 835 | 2.600 |
Why?
|
Hyperlipidemias | 4 | 2024 | 771 | 2.440 |
Why?
|
United States | 126 | 2024 | 72339 | 2.390 |
Why?
|
Heart Failure | 25 | 2024 | 11674 | 2.000 |
Why?
|
Quality of Health Care | 13 | 2024 | 4330 | 1.910 |
Why?
|
Hospitals | 15 | 2024 | 3882 | 1.770 |
Why?
|
Quality Indicators, Health Care | 6 | 2020 | 1792 | 1.720 |
Why?
|
Health Policy | 6 | 2024 | 2684 | 1.700 |
Why?
|
Healthcare Disparities | 12 | 2022 | 3357 | 1.680 |
Why?
|
Hospitalization | 23 | 2024 | 10718 | 1.600 |
Why?
|
Homeless Youth | 2 | 2022 | 48 | 1.580 |
Why?
|
Medicare Part C | 5 | 2023 | 334 | 1.530 |
Why?
|
Diabetes Mellitus | 8 | 2024 | 5840 | 1.500 |
Why?
|
Fee-for-Service Plans | 11 | 2024 | 700 | 1.460 |
Why?
|
Insurance, Health | 6 | 2024 | 2497 | 1.440 |
Why?
|
Reimbursement Mechanisms | 3 | 2020 | 667 | 1.350 |
Why?
|
Eligibility Determination | 4 | 2024 | 421 | 1.330 |
Why?
|
Pneumonia | 8 | 2024 | 2140 | 1.270 |
Why?
|
Prescription Drugs | 4 | 2024 | 631 | 1.220 |
Why?
|
Reimbursement, Incentive | 4 | 2024 | 543 | 1.220 |
Why?
|
Delivery of Health Care | 7 | 2024 | 5335 | 1.190 |
Why?
|
Poverty | 10 | 2024 | 2697 | 1.170 |
Why?
|
Health Services Accessibility | 13 | 2024 | 5441 | 1.140 |
Why?
|
Cross-Sectional Studies | 30 | 2024 | 26112 | 1.060 |
Why?
|
Cardiology | 3 | 2024 | 1667 | 1.020 |
Why?
|
Humans | 168 | 2024 | 761423 | 0.970 |
Why?
|
Coronary Artery Bypass | 6 | 2024 | 2189 | 0.970 |
Why?
|
Rural Population | 4 | 2024 | 2285 | 0.930 |
Why?
|
Hypertension | 6 | 2024 | 8542 | 0.930 |
Why?
|
Patient Protection and Affordable Care Act | 7 | 2023 | 1188 | 0.910 |
Why?
|
Social Class | 3 | 2024 | 2004 | 0.890 |
Why?
|
Pulmonary Embolism | 3 | 2024 | 2566 | 0.850 |
Why?
|
Hospital Mortality | 14 | 2024 | 5291 | 0.850 |
Why?
|
Empiricism | 1 | 2022 | 7 | 0.840 |
Why?
|
Aged | 68 | 2024 | 169235 | 0.820 |
Why?
|
Budgets | 1 | 2024 | 230 | 0.800 |
Why?
|
Stroke | 5 | 2024 | 9756 | 0.790 |
Why?
|
Drug Costs | 4 | 2024 | 1183 | 0.780 |
Why?
|
Health Expenditures | 10 | 2024 | 2366 | 0.780 |
Why?
|
Prospective Payment System | 1 | 2022 | 136 | 0.760 |
Why?
|
Heart | 6 | 2024 | 4405 | 0.720 |
Why?
|
Health Care Reform | 2 | 2022 | 1246 | 0.720 |
Why?
|
Insurance Benefits | 3 | 2024 | 187 | 0.710 |
Why?
|
Insurance Coverage | 4 | 2024 | 1940 | 0.700 |
Why?
|
Morals | 1 | 2023 | 289 | 0.700 |
Why?
|
Hospitals, Rural | 1 | 2022 | 176 | 0.690 |
Why?
|
Hospitals, Urban | 1 | 2022 | 500 | 0.680 |
Why?
|
Rural Health | 1 | 2021 | 297 | 0.660 |
Why?
|
Coronary Disease | 2 | 2024 | 5919 | 0.660 |
Why?
|
Income | 3 | 2024 | 1876 | 0.650 |
Why?
|
Substance-Related Disorders | 5 | 2024 | 4420 | 0.650 |
Why?
|
Rural Health Services | 1 | 2022 | 384 | 0.640 |
Why?
|
Financing, Government | 1 | 2022 | 472 | 0.630 |
Why?
|
Heart Diseases | 2 | 2022 | 2785 | 0.630 |
Why?
|
Urban Health | 1 | 2021 | 533 | 0.620 |
Why?
|
Health Status Disparities | 5 | 2023 | 1852 | 0.610 |
Why?
|
Medicare Part D | 1 | 2023 | 355 | 0.600 |
Why?
|
Government Programs | 1 | 2020 | 279 | 0.600 |
Why?
|
Peripheral Arterial Disease | 3 | 2023 | 1272 | 0.590 |
Why?
|
Costs and Cost Analysis | 5 | 2023 | 1668 | 0.580 |
Why?
|
Food Supply | 1 | 2023 | 544 | 0.580 |
Why?
|
Male | 68 | 2024 | 360736 | 0.570 |
Why?
|
Adult | 43 | 2024 | 221148 | 0.570 |
Why?
|
Mandatory Reporting | 1 | 2018 | 123 | 0.570 |
Why?
|
Mortality | 5 | 2021 | 2900 | 0.570 |
Why?
|
Endovascular Procedures | 4 | 2023 | 2181 | 0.570 |
Why?
|
Managed Care Programs | 1 | 2022 | 940 | 0.560 |
Why?
|
Health Services Misuse | 1 | 2019 | 244 | 0.560 |
Why?
|
Workload | 3 | 2019 | 844 | 0.540 |
Why?
|
Hospital Costs | 3 | 2019 | 948 | 0.530 |
Why?
|
Physicians, Primary Care | 1 | 2022 | 623 | 0.520 |
Why?
|
Health Care Costs | 4 | 2024 | 3243 | 0.520 |
Why?
|
Female | 66 | 2024 | 392581 | 0.510 |
Why?
|
Ambulatory Care | 3 | 2024 | 2775 | 0.490 |
Why?
|
Embolectomy | 1 | 2016 | 129 | 0.490 |
Why?
|
Angina, Unstable | 1 | 2019 | 888 | 0.470 |
Why?
|
Pandemics | 13 | 2024 | 8641 | 0.470 |
Why?
|
Cardiovascular Surgical Procedures | 3 | 2010 | 189 | 0.470 |
Why?
|
Cerebrovascular Disorders | 1 | 2021 | 1474 | 0.460 |
Why?
|
Choice Behavior | 2 | 2021 | 824 | 0.440 |
Why?
|
New York | 4 | 2020 | 874 | 0.430 |
Why?
|
Medically Uninsured | 5 | 2024 | 836 | 0.430 |
Why?
|
Disclosure | 1 | 2019 | 748 | 0.430 |
Why?
|
Patient Discharge | 9 | 2024 | 3441 | 0.420 |
Why?
|
Middle Aged | 36 | 2024 | 220826 | 0.420 |
Why?
|
Vena Cava Filters | 1 | 2016 | 261 | 0.420 |
Why?
|
Coronary Angiography | 3 | 2020 | 4472 | 0.410 |
Why?
|
Risk Assessment | 7 | 2024 | 23990 | 0.410 |
Why?
|
International Classification of Diseases | 4 | 2022 | 909 | 0.410 |
Why?
|
Mental Disorders | 2 | 2022 | 6841 | 0.400 |
Why?
|
Mediastinum | 2 | 2024 | 267 | 0.400 |
Why?
|
Sarcoidosis | 1 | 2017 | 521 | 0.400 |
Why?
|
Risk Factors | 19 | 2024 | 74167 | 0.400 |
Why?
|
American Heart Association | 5 | 2024 | 1045 | 0.390 |
Why?
|
Quality Improvement | 3 | 2022 | 3800 | 0.390 |
Why?
|
Uterine Cervical Neoplasms | 1 | 2024 | 2019 | 0.380 |
Why?
|
Retrospective Studies | 31 | 2024 | 80582 | 0.380 |
Why?
|
Thrombolytic Therapy | 2 | 2022 | 2065 | 0.380 |
Why?
|
Lipids | 1 | 2022 | 3340 | 0.370 |
Why?
|
Registries | 10 | 2023 | 8223 | 0.370 |
Why?
|
Cardiology Service, Hospital | 3 | 2018 | 239 | 0.370 |
Why?
|
Hydroxymethylglutaryl-CoA Reductase Inhibitors | 2 | 2024 | 3244 | 0.370 |
Why?
|
Brain Ischemia | 1 | 2024 | 3049 | 0.350 |
Why?
|
Aged, 80 and over | 20 | 2024 | 58956 | 0.340 |
Why?
|
Coronary Artery Disease | 3 | 2024 | 6395 | 0.340 |
Why?
|
Anticoagulants | 3 | 2016 | 4813 | 0.340 |
Why?
|
Minority Groups | 5 | 2024 | 1203 | 0.340 |
Why?
|
Task Performance and Analysis | 3 | 2010 | 761 | 0.330 |
Why?
|
Florida | 3 | 2020 | 431 | 0.330 |
Why?
|
Monoclonal Gammopathy of Undetermined Significance | 1 | 2011 | 180 | 0.320 |
Why?
|
Nutrition Surveys | 4 | 2024 | 1728 | 0.320 |
Why?
|
Residence Characteristics | 5 | 2022 | 2092 | 0.320 |
Why?
|
Coronavirus Infections | 3 | 2020 | 3082 | 0.310 |
Why?
|
Pneumonia, Viral | 3 | 2020 | 3202 | 0.300 |
Why?
|
Critical Illness | 2 | 2017 | 2723 | 0.300 |
Why?
|
Paraproteinemias | 1 | 2010 | 248 | 0.290 |
Why?
|
Cost Savings | 3 | 2024 | 913 | 0.290 |
Why?
|
Treatment Outcome | 14 | 2024 | 64651 | 0.290 |
Why?
|
Operating Rooms | 3 | 2010 | 790 | 0.280 |
Why?
|
Warfarin | 2 | 2015 | 1483 | 0.280 |
Why?
|
Cholesterol, LDL | 1 | 2015 | 2382 | 0.260 |
Why?
|
Home Care Services | 2 | 2024 | 648 | 0.260 |
Why?
|
Fibrinolytic Agents | 1 | 2016 | 2084 | 0.260 |
Why?
|
Telemedicine | 1 | 2023 | 3051 | 0.260 |
Why?
|
Cohort Studies | 10 | 2024 | 41446 | 0.260 |
Why?
|
Time Factors | 12 | 2024 | 39975 | 0.260 |
Why?
|
Cardiomyopathies | 1 | 2017 | 1964 | 0.260 |
Why?
|
Poland | 2 | 2024 | 198 | 0.240 |
Why?
|
Prevalence | 5 | 2023 | 15717 | 0.240 |
Why?
|
Cardiopulmonary Bypass | 1 | 2010 | 1094 | 0.240 |
Why?
|
Echocardiography | 4 | 2018 | 4991 | 0.230 |
Why?
|
Cholesterol | 2 | 2024 | 2902 | 0.230 |
Why?
|
Colorectal Neoplasms | 1 | 2024 | 6935 | 0.230 |
Why?
|
Inflation, Economic | 1 | 2023 | 30 | 0.220 |
Why?
|
Outpatients | 2 | 2024 | 1597 | 0.220 |
Why?
|
Limb Salvage | 2 | 2023 | 481 | 0.220 |
Why?
|
Viscera | 1 | 2024 | 138 | 0.220 |
Why?
|
Antihypertensive Agents | 2 | 2024 | 2023 | 0.220 |
Why?
|
Risk | 4 | 2021 | 9612 | 0.210 |
Why?
|
Hospital Bed Capacity | 2 | 2020 | 206 | 0.200 |
Why?
|
Diagnosis-Related Groups | 1 | 2024 | 449 | 0.200 |
Why?
|
Pharmaceutical Services | 1 | 2024 | 141 | 0.200 |
Why?
|
Health Services Research | 2 | 2020 | 1812 | 0.200 |
Why?
|
Quality of Life | 1 | 2024 | 13361 | 0.200 |
Why?
|
Policy | 2 | 2023 | 508 | 0.200 |
Why?
|
Clinical Coding | 2 | 2020 | 181 | 0.200 |
Why?
|
Adolescent | 8 | 2024 | 88313 | 0.190 |
Why?
|
Cause of Death | 3 | 2021 | 3684 | 0.190 |
Why?
|
Preventive Health Services | 2 | 2024 | 567 | 0.190 |
Why?
|
Socioeconomic Factors | 5 | 2021 | 7825 | 0.190 |
Why?
|
Age Factors | 5 | 2021 | 18400 | 0.190 |
Why?
|
Young Adult | 7 | 2024 | 59207 | 0.190 |
Why?
|
Food Handling | 3 | 2006 | 154 | 0.190 |
Why?
|
Retirement | 1 | 2022 | 198 | 0.190 |
Why?
|
Prostatic Neoplasms | 1 | 2024 | 11118 | 0.190 |
Why?
|
State Government | 1 | 2024 | 384 | 0.180 |
Why?
|
Amyloid Neuropathies, Familial | 1 | 2023 | 151 | 0.180 |
Why?
|
Neprilysin | 1 | 2023 | 478 | 0.180 |
Why?
|
Endocarditis | 1 | 2024 | 350 | 0.170 |
Why?
|
Angina Pectoris | 1 | 2024 | 959 | 0.170 |
Why?
|
Social Responsibility | 1 | 2022 | 386 | 0.170 |
Why?
|
Population Density | 1 | 2020 | 193 | 0.170 |
Why?
|
Motivation | 2 | 2020 | 2006 | 0.170 |
Why?
|
Nursing Staff | 1 | 2020 | 113 | 0.170 |
Why?
|
Episode of Care | 1 | 2019 | 128 | 0.160 |
Why?
|
Communication | 4 | 2020 | 3871 | 0.160 |
Why?
|
Health Facilities | 1 | 2024 | 580 | 0.160 |
Why?
|
Drugs, Generic | 1 | 2024 | 448 | 0.160 |
Why?
|
Life Style | 2 | 2024 | 3914 | 0.160 |
Why?
|
Aortic Valve Stenosis | 2 | 2022 | 2009 | 0.160 |
Why?
|
Survival Rate | 4 | 2020 | 12720 | 0.150 |
Why?
|
Michigan | 1 | 2019 | 339 | 0.150 |
Why?
|
Employment | 1 | 2024 | 1118 | 0.150 |
Why?
|
Washington | 1 | 2018 | 315 | 0.150 |
Why?
|
Aortic Valve Insufficiency | 1 | 2022 | 579 | 0.150 |
Why?
|
Databases, Factual | 5 | 2024 | 7956 | 0.150 |
Why?
|
Mental Health | 2 | 2022 | 3249 | 0.150 |
Why?
|
New York City | 1 | 2020 | 731 | 0.150 |
Why?
|
Drug Utilization | 2 | 2020 | 1188 | 0.150 |
Why?
|
Hospital Administration | 1 | 2021 | 353 | 0.140 |
Why?
|
Meat Products | 3 | 2006 | 96 | 0.140 |
Why?
|
Obesity | 3 | 2024 | 12938 | 0.140 |
Why?
|
Primary Prevention | 1 | 2024 | 1186 | 0.140 |
Why?
|
Patient Care | 1 | 2022 | 621 | 0.140 |
Why?
|
Physician Incentive Plans | 1 | 2018 | 164 | 0.140 |
Why?
|
Breast Neoplasms | 1 | 2024 | 21012 | 0.130 |
Why?
|
Hypercholesterolemia | 1 | 2023 | 1141 | 0.130 |
Why?
|
Bradycardia | 1 | 2017 | 299 | 0.130 |
Why?
|
Medical Records | 2 | 2018 | 1407 | 0.130 |
Why?
|
Atrioventricular Block | 1 | 2017 | 133 | 0.130 |
Why?
|
Bundle-Branch Block | 1 | 2017 | 278 | 0.130 |
Why?
|
Lower Extremity | 1 | 2023 | 1201 | 0.130 |
Why?
|
Vulnerable Populations | 1 | 2021 | 703 | 0.130 |
Why?
|
Politics | 1 | 2022 | 815 | 0.130 |
Why?
|
Comorbidity | 5 | 2024 | 10498 | 0.120 |
Why?
|
Ischemia | 1 | 2023 | 1877 | 0.120 |
Why?
|
Ontario | 3 | 2022 | 398 | 0.120 |
Why?
|
Certification | 1 | 2018 | 418 | 0.120 |
Why?
|
Atrial Fibrillation | 2 | 2024 | 5127 | 0.120 |
Why?
|
Interprofessional Relations | 3 | 2010 | 991 | 0.120 |
Why?
|
Syncope | 1 | 2017 | 427 | 0.120 |
Why?
|
California | 1 | 2019 | 1427 | 0.120 |
Why?
|
Policy Making | 1 | 2018 | 542 | 0.120 |
Why?
|
Pacemaker, Artificial | 1 | 2020 | 808 | 0.120 |
Why?
|
Cost of Illness | 1 | 2024 | 1936 | 0.120 |
Why?
|
Patients | 1 | 2021 | 906 | 0.120 |
Why?
|
Practice Guidelines as Topic | 4 | 2024 | 7389 | 0.120 |
Why?
|
Prostate-Specific Antigen | 1 | 2024 | 2469 | 0.110 |
Why?
|
Massachusetts | 4 | 2020 | 8832 | 0.110 |
Why?
|
Diabetes Mellitus, Type 2 | 3 | 2023 | 12143 | 0.110 |
Why?
|
Urban Population | 1 | 2022 | 2036 | 0.110 |
Why?
|
Multiple Myeloma | 1 | 2011 | 5146 | 0.110 |
Why?
|
Leadership | 3 | 2020 | 1385 | 0.110 |
Why?
|
Health Services Needs and Demand | 1 | 2021 | 1403 | 0.110 |
Why?
|
Nursing Homes | 1 | 2020 | 1082 | 0.100 |
Why?
|
Tomography, Emission-Computed, Single-Photon | 1 | 2017 | 1068 | 0.100 |
Why?
|
Guideline Adherence | 3 | 2018 | 2220 | 0.100 |
Why?
|
Monitoring, Physiologic | 1 | 2020 | 1780 | 0.100 |
Why?
|
Myocardial Perfusion Imaging | 1 | 2017 | 575 | 0.100 |
Why?
|
Influenza, Human | 1 | 2023 | 1521 | 0.100 |
Why?
|
Health Resources | 1 | 2018 | 935 | 0.100 |
Why?
|
Prognosis | 5 | 2021 | 29620 | 0.100 |
Why?
|
History, 21st Century | 1 | 2018 | 1567 | 0.100 |
Why?
|
Unnecessary Procedures | 1 | 2015 | 415 | 0.100 |
Why?
|
Cost-Benefit Analysis | 3 | 2020 | 5492 | 0.100 |
Why?
|
Health Status | 1 | 2024 | 4075 | 0.100 |
Why?
|
Internet | 1 | 2023 | 3092 | 0.090 |
Why?
|
Population Surveillance | 1 | 2021 | 2597 | 0.090 |
Why?
|
Medical Errors | 2 | 2010 | 1260 | 0.090 |
Why?
|
Catheter Ablation | 1 | 2024 | 2752 | 0.090 |
Why?
|
Health Knowledge, Attitudes, Practice | 3 | 2021 | 4014 | 0.090 |
Why?
|
Length of Stay | 2 | 2021 | 6422 | 0.090 |
Why?
|
Defibrillators, Implantable | 1 | 2020 | 1490 | 0.090 |
Why?
|
Severity of Illness Index | 3 | 2018 | 15838 | 0.090 |
Why?
|
Catheterization | 1 | 2016 | 1432 | 0.090 |
Why?
|
Dentures | 1 | 2010 | 12 | 0.090 |
Why?
|
Information Dissemination | 1 | 2018 | 1126 | 0.090 |
Why?
|
Exercise Test | 1 | 2017 | 2129 | 0.090 |
Why?
|
History, 20th Century | 1 | 2018 | 2769 | 0.080 |
Why?
|
Early Detection of Cancer | 1 | 2024 | 3201 | 0.080 |
Why?
|
Blood Glucose | 1 | 2024 | 6391 | 0.080 |
Why?
|
Food Packaging | 2 | 2006 | 13 | 0.080 |
Why?
|
Branchioma | 1 | 2008 | 17 | 0.080 |
Why?
|
Aerospace Medicine | 1 | 2010 | 95 | 0.080 |
Why?
|
Fluorodeoxyglucose F18 | 1 | 2017 | 2010 | 0.080 |
Why?
|
Sex Factors | 2 | 2020 | 10548 | 0.080 |
Why?
|
Branchio-Oto-Renal Syndrome | 1 | 2008 | 25 | 0.080 |
Why?
|
Anticholesteremic Agents | 1 | 2015 | 967 | 0.080 |
Why?
|
Acute Disease | 1 | 2019 | 7238 | 0.080 |
Why?
|
Insulin | 1 | 2022 | 6602 | 0.070 |
Why?
|
Radiopharmaceuticals | 1 | 2017 | 2651 | 0.070 |
Why?
|
Public Health | 1 | 2021 | 2666 | 0.070 |
Why?
|
Ownership | 2 | 2020 | 339 | 0.070 |
Why?
|
Patient Satisfaction | 1 | 2020 | 3460 | 0.070 |
Why?
|
Health Personnel | 1 | 2021 | 3335 | 0.070 |
Why?
|
Veterans | 1 | 2021 | 2647 | 0.070 |
Why?
|
Emergency Service, Hospital | 3 | 2024 | 7874 | 0.070 |
Why?
|
Administration, Oral | 1 | 2014 | 4016 | 0.070 |
Why?
|
Predictive Value of Tests | 3 | 2019 | 15262 | 0.070 |
Why?
|
Prospective Studies | 5 | 2024 | 54415 | 0.060 |
Why?
|
Morbidity | 2 | 2021 | 1750 | 0.060 |
Why?
|
Foreign Bodies | 1 | 2010 | 402 | 0.060 |
Why?
|
Escherichia coli O157 | 1 | 2005 | 53 | 0.060 |
Why?
|
Sex Distribution | 1 | 2010 | 2281 | 0.060 |
Why?
|
Larynx | 1 | 2010 | 492 | 0.060 |
Why?
|
Salmonella | 1 | 2005 | 125 | 0.060 |
Why?
|
Food Contamination | 1 | 2006 | 191 | 0.060 |
Why?
|
Equipment Contamination | 1 | 2006 | 181 | 0.060 |
Why?
|
Deafness | 1 | 2008 | 459 | 0.060 |
Why?
|
Electrocardiography | 1 | 2017 | 6384 | 0.060 |
Why?
|
Clinical Protocols | 1 | 2010 | 1440 | 0.060 |
Why?
|
Ukraine | 1 | 2024 | 149 | 0.060 |
Why?
|
Streptococcus pyogenes | 1 | 2006 | 292 | 0.060 |
Why?
|
Evidence-Based Medicine | 1 | 2015 | 3687 | 0.060 |
Why?
|
Listeria monocytogenes | 1 | 2005 | 249 | 0.060 |
Why?
|
Diuresis | 1 | 2023 | 106 | 0.060 |
Why?
|
Incidence | 3 | 2024 | 21341 | 0.060 |
Why?
|
Education, Medical | 1 | 2015 | 1725 | 0.050 |
Why?
|
Chickens | 1 | 2005 | 859 | 0.050 |
Why?
|
Thoracic Surgery | 1 | 2009 | 722 | 0.050 |
Why?
|
Single-Blind Method | 2 | 2017 | 1571 | 0.050 |
Why?
|
Meat | 1 | 2005 | 584 | 0.050 |
Why?
|
Positron-Emission Tomography | 1 | 2017 | 6485 | 0.050 |
Why?
|
Abnormalities, Multiple | 1 | 2008 | 1424 | 0.050 |
Why?
|
Cardiac Surgical Procedures | 2 | 2024 | 3630 | 0.050 |
Why?
|
Attitude of Health Personnel | 1 | 2015 | 3889 | 0.050 |
Why?
|
Colony Count, Microbial | 3 | 2006 | 330 | 0.050 |
Why?
|
Translating | 1 | 2022 | 143 | 0.050 |
Why?
|
Prescriptions | 1 | 2023 | 386 | 0.040 |
Why?
|
Patient Care Team | 2 | 2010 | 2523 | 0.040 |
Why?
|
Diuretics | 1 | 2023 | 610 | 0.040 |
Why?
|
Preoperative Care | 1 | 2009 | 2242 | 0.040 |
Why?
|
Hot Temperature | 1 | 2005 | 1440 | 0.040 |
Why?
|
Communication Barriers | 1 | 2022 | 413 | 0.040 |
Why?
|
Hospitals, Veterans | 1 | 2021 | 395 | 0.040 |
Why?
|
Device Approval | 1 | 2020 | 163 | 0.040 |
Why?
|
Follow-Up Studies | 3 | 2020 | 39117 | 0.040 |
Why?
|
Survival Analysis | 1 | 2011 | 10089 | 0.040 |
Why?
|
Femoral Artery | 1 | 2022 | 827 | 0.040 |
Why?
|
Pulmonary Veins | 1 | 2024 | 746 | 0.040 |
Why?
|
Quality Assurance, Health Care | 1 | 2008 | 2169 | 0.040 |
Why?
|
Sodium | 1 | 2023 | 1588 | 0.040 |
Why?
|
Myocardial Revascularization | 1 | 2021 | 792 | 0.040 |
Why?
|
Algorithms | 1 | 2018 | 14026 | 0.040 |
Why?
|
Aftercare | 1 | 2023 | 914 | 0.040 |
Why?
|
Staphylococcus aureus | 1 | 2005 | 1458 | 0.030 |
Why?
|
Angiotensin Receptor Antagonists | 1 | 2023 | 1039 | 0.030 |
Why?
|
Personnel Staffing and Scheduling | 1 | 2020 | 495 | 0.030 |
Why?
|
Food Microbiology | 2 | 2006 | 74 | 0.030 |
Why?
|
Diffusion of Innovation | 1 | 2020 | 728 | 0.030 |
Why?
|
Consumer Product Safety | 2 | 2006 | 122 | 0.030 |
Why?
|
Interdisciplinary Communication | 1 | 2020 | 931 | 0.030 |
Why?
|
Reference Standards | 1 | 2018 | 1004 | 0.030 |
Why?
|
Ileostomy | 1 | 2015 | 121 | 0.030 |
Why?
|
Age of Onset | 1 | 2021 | 3304 | 0.030 |
Why?
|
Disease Progression | 1 | 2011 | 13502 | 0.030 |
Why?
|
Patient Admission | 1 | 2021 | 1367 | 0.030 |
Why?
|
Fibrinolysis | 1 | 2015 | 332 | 0.030 |
Why?
|
Radiology Information Systems | 1 | 2018 | 529 | 0.030 |
Why?
|
Drug Approval | 1 | 2020 | 814 | 0.030 |
Why?
|
Cooperative Behavior | 1 | 2020 | 1504 | 0.030 |
Why?
|
Regression Analysis | 1 | 2022 | 6343 | 0.030 |
Why?
|
Health Care Surveys | 1 | 2020 | 2426 | 0.030 |
Why?
|
Program Development | 1 | 2019 | 1298 | 0.030 |
Why?
|
Enoxaparin | 1 | 2015 | 391 | 0.030 |
Why?
|
Clinical Competence | 1 | 2008 | 4793 | 0.030 |
Why?
|
Language | 1 | 2022 | 1539 | 0.030 |
Why?
|
Aortic Valve | 1 | 2022 | 1961 | 0.030 |
Why?
|
Thrombophilia | 1 | 2015 | 305 | 0.030 |
Why?
|
Cognition | 1 | 2010 | 6986 | 0.030 |
Why?
|
Geriatric Assessment | 1 | 2019 | 1409 | 0.020 |
Why?
|
Referral and Consultation | 1 | 2024 | 3600 | 0.020 |
Why?
|
Glucose | 1 | 2023 | 4347 | 0.020 |
Why?
|
Program Evaluation | 1 | 2019 | 2494 | 0.020 |
Why?
|
Magnetic Resonance Imaging | 1 | 2017 | 36423 | 0.020 |
Why?
|
Time Management | 1 | 2010 | 52 | 0.020 |
Why?
|
Thrombectomy | 1 | 2015 | 705 | 0.020 |
Why?
|
Colectomy | 1 | 2015 | 688 | 0.020 |
Why?
|
Hypoglycemic Agents | 1 | 2022 | 3081 | 0.020 |
Why?
|
Stroke Volume | 1 | 2023 | 5497 | 0.020 |
Why?
|
Pilot Projects | 2 | 2015 | 8633 | 0.020 |
Why?
|
Temperature | 2 | 2006 | 2228 | 0.020 |
Why?
|
Abdominal Pain | 1 | 2015 | 1071 | 0.020 |
Why?
|
Animals | 4 | 2015 | 168441 | 0.020 |
Why?
|
Observation | 1 | 2010 | 310 | 0.020 |
Why?
|
Ear | 1 | 2008 | 172 | 0.020 |
Why?
|
Minnesota | 1 | 2008 | 339 | 0.020 |
Why?
|
Postoperative Complications | 2 | 2024 | 15650 | 0.020 |
Why?
|
Physician-Patient Relations | 1 | 2020 | 3249 | 0.020 |
Why?
|
Proportional Hazards Models | 1 | 2021 | 12456 | 0.020 |
Why?
|
Cheese | 1 | 2006 | 38 | 0.020 |
Why?
|
Multivariate Analysis | 1 | 2019 | 12058 | 0.020 |
Why?
|
Tracheostomy | 1 | 2010 | 426 | 0.020 |
Why?
|
Vocal Cords | 1 | 2010 | 522 | 0.020 |
Why?
|
Logistic Models | 1 | 2019 | 13255 | 0.020 |
Why?
|
Body Mass Index | 1 | 2022 | 12951 | 0.010 |
Why?
|
Safety Management | 1 | 2010 | 760 | 0.010 |
Why?
|
Software | 1 | 2018 | 4434 | 0.010 |
Why?
|
Causality | 1 | 2010 | 1243 | 0.010 |
Why?
|
Cooking | 1 | 2005 | 315 | 0.010 |
Why?
|
Focus Groups | 1 | 2009 | 1413 | 0.010 |
Why?
|
Colitis, Ulcerative | 1 | 2015 | 1922 | 0.010 |
Why?
|
Infant, Newborn | 1 | 2020 | 26212 | 0.010 |
Why?
|
Cattle | 1 | 2005 | 3848 | 0.010 |
Why?
|
Infant | 1 | 2020 | 36205 | 0.010 |
Why?
|
Feasibility Studies | 1 | 2009 | 5246 | 0.010 |
Why?
|
Child, Preschool | 1 | 2020 | 42254 | 0.010 |
Why?
|
Diagnosis, Differential | 1 | 2008 | 12970 | 0.010 |
Why?
|
Kidney | 1 | 2008 | 7049 | 0.010 |
Why?
|
Child | 1 | 2020 | 80162 | 0.010 |
Why?
|
Tomography, X-Ray Computed | 1 | 2015 | 20556 | 0.010 |
Why?
|
Models, Biological | 1 | 2005 | 9469 | 0.000 |
Why?
|